Common food allergens in children with respiratory allergic symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 136s Year: 2003
Is prevalence of asthma, respiratory symptoms and allergic sensitisation still increasing in Swedish children? Source: Annual Congress 2007 - Allergy and asthma - environmental and metabolic risk factors Year: 2007
Associations between food allergy and respiratory manifestations in a population-based sample of children Source: Eur Respir J 2004; 24: Suppl. 48, 170s Year: 2004
Asthma and allergic rhinitis increase respiratory symptoms and disability in cold weather Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
Fewer allergic respiratory disorders among farmers' children in a closed birth cohort from Sweden Source: Eur Respir J 2001; 17: 1151-1157 Year: 2001
The German severe asthma register Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Swimming pool attendance and risk of asthma and allergic symptoms in children Source: Eur Respir J 2009; 34: 1304-1310 Year: 2009
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 3 UK centres Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 4 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Prevalence estimates of current asthma and chronic cough/phlegm, but not of allergic rhinitis, are strongly related to response percentage in a mail survey Source: Eur Respir J 2007; 30: Suppl. 51, 149s Year: 2007
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Should patients with mild asthma be excluded from allergic rhinitis drug trials? Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
The co-morbidity of allergic hay fever, asthma and related disorders in randomly selected patients with respiratory allergic diseases Source: Annual Congress 2005 - Environmental factors, allergy and asthma Year: 2005
The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016
Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018
Drug hypersensitivity and food allergy in subjects with persistent asthma Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Childhood allergic sensitisation and respiratory manifestations. 6C study-France Source: Eur Respir J 2007; 30: Suppl. 51, 399s Year: 2007
Respiratory symptoms and asthma among swimming pool workers – results from a questionnaire study Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008